It has been three years since 10 countries—Cyprus, Czech Republic, Estonia, Hungary, Latvia, Lithuania, Malta, Poland, Slovakia and Slovenia—joined the EU (EU 10), adding 5% to the GDP of the world’s largest economy. In January, Bulgaria and Romania also became members the EU. EU membership has strengthened new member states’ (NMS) trade status, financial stability […]
The 2007 EU Industrial R&D Investment Scoreboard shows aggregate R&D spending by 2,000 of the world’s top companies rose 10% in fiscal 2006 to €371.6 billion ($464.5 billion). R&D expenditures by the 1,000 non-EU companies surveyed rose 11.1% to €250.5 billion ($313.1 billion), compared to 7.7% in 2005. R&D spending for the 1,000 EU companies […]
The government has submitted its 2007 Comprehensive Spending Review (CSR07), which sets its spending plans for 2008–09, 2009–10 and 2010–11. Of CSR07’s allocations to the Department for Innovation, Universities and Skills, research funding will total £5.6 billion ($11.4 billion) for 2008–09, £5.9 billion for 2009–10 and £6.3 billion for 2010–11. Funding for the Department for […]
The “competitiveness clusters” (pôles de competitivité) initiative, instituted in 2004 with an allocation of €1.5 billion ($1.85 billion) to be spent by the end of 2008, was established in order to develop the commercial potential of innovation. Of this €1.5 billion, €732 million was to be distributed to R&D for projects, €575 million was to […]
China is already the world’s leading producer of drug raw materials, and it is beginning to make its first steps into the generics market. This summer, Zhejiang Huahai Pharmaceutical, a pharmaceuticals firm based in Linhai, became the first Chinese company to be approved to export drugs to the US. Huahai’s generic version of nevirapine—an AIDS […]
The history of London, England’s laboratory product exhibitions is long and varied. There used to be a very successful lab exhibition and scientific conference in London called The British Laboratory Week, or Lab Week for short (fancy that, a whole week). Some 20 years ago, a competing event was launched and the British lab scene […]
Holliston, MA 10/11/07—Harvard Bioscience has acquired Panlab for $5.0 million in cash. Panlab manufactures and distributes life science instruments, primarily for the neuroscience research market. “With the acquisition of Panlab, we are able to expand our distribution channels by establishing a subsidiary in Spain. In addition, the acquisition provides us access into a segment of […]
France’s 2008 budget, which was announced this month, provides a €1.88 billion ($2.66 billion) boost to the budget for higher education and research, an increase of 7.8%. From this funding increase, €1 billion ($1.4 billion) will go to higher education and €880 million ($1.2 billion) will go to research. Funding for research includes a €22 […]
According to data published in September by the German Federal Ministry of Education and Research (BMBF) and the Stifterverband, the German association of research sponsors, public and private R&D spending is increasing. Public R&D funding is expected to increase 8% to €9.2 billion ($12.9 billion) in 2008. The Stifterverband calculates that industry R&D spending grew […]
The construction of new laboratories is growing in Asia, driven by government funding (see page 7) and manufacturing and R&D investment from the West. China’s Ministry of Science and Technology alone has approved the construction of 27 “national key laboratories” this year. China’s Ministry of Commerce reported this month that over 1,000 R&D centers have […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
